Katherine Bach Kalin, Director at SELLAS Life Sciences Group, Inc. (SLS), bought 63,400 shares at $1.59 ($101K) on 2025-11-19, disclosed to the SEC on 2025-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.